Skip to main content
Retour
Watch Compare

Polomar Health Services, Inc.

Qualité des données : 100%
PMHS
OTC Manufacturing Chemicals
0,16 €
0,00 € (0,00%)
6 months return
—
Momentum
Neutral
ROE
-30,08%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)70,38%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-30,08%
Au-dessus de la moyenne du secteur (-54,68%)
ROIC-22,45%
Net Margin-6562,42%
Op. Margin-6199,82%

Sécurité

Debt / Equity
N/A
Current Ratio0,13
Interest Coverage-17,10

Valorisation

PE (TTM)
-1,85
En dessous de la moyenne du secteur (-1,49)
P/B Ratio0,58
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -991 904,0
Capital intensive — 245,36% of revenue goes to capex

Price History

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 70,38% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -30,08% · Net Margin: -6562,42%
Revenue (TTM) 37 044,0 Net Income (TTM) -2,43 M
ROE -30,08% ROA -26,00%
Gross Margin 55,09% Operating Margin -6199,82%
Net Margin -6562,42% Free Cash Flow (TTM) -991 904,0
ROIC -22,45% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0,13
Debt / Equity N/A Current Ratio 0,13
Interest Coverage -17,10 Asset Turnover 0,00
Working Capital -1,31 M Tangible Book Value 7,77 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -1,85 · EV/EBITDA: N/A
P/E Ratio -1,85 Forward P/E N/A
P/B Ratio 0,58 P/S Ratio 121,17
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -22,10%
Market Cap 4,49 M Enterprise Value 4,45 M

Per Share

EPS: -0,09 · FCF/Share: -0,04
EPS (Diluted TTM) -0,09 Revenue / Share 0,00
FCF / Share -0,04 OCF / Share -0,03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 40,80% · CapEx/Rev: 245,36%
CapEx / Revenue 245,36% FCF Conversion 40,80%
SBC-Adj. FCF -1,12 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023
Revenue 58 824,0 34 526,0
Net Income -1,34 M -416 500,0
EPS (Diluted) -0,05 -0,02
Gross Profit 30 903,0 34 526,0
Operating Income -1,30 M -269 830,0
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A 263 280,0 —
Interest Expense 41 837,0 —
Income Tax — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023
Total Assets 9,95 M 244,0
Total Liabilities 1,35 M 13 783,0
Shareholders' Equity 8,60 M -13 539,0
Total Debt — —
Cash & Equivalents 6 191,0 224,0
Current Assets 76 813,0 244,0
Current Liabilities 1,34 M 13 783,0

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -1,9 -1,5
P/B 0,6 1,6
ROE % -30,1 -54,7
Net Margin % -6562,4 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3